Comparison of five cell cycle analysis models applied to 1414 flow cytometric DNA histograms of fresh frozen breast cancer

Communications in Clinical Cytometry

Volumn 30, Issue 1, 1997, Pages 54-60

  Bergers, Elisabeth ^a   Van Diest, Paul J ^a   Baak, Jan P A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

breast cancer; cell cycle analysis; DNA flow cytometry

Indexed keywords

DNA;

ARTICLE; BREAST CANCER; CELL CYCLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HISTOGRAM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; TECHNIQUE;

BREAST NEOPLASMS; CELL CYCLE; CRYOPRESERVATION; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; FREEZING; HUMANS; MODELS, GENETIC;

EID: 0030916701     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19970215)30:1<54::AID-CYTO8>3.0.CO;2-F     Document Type: Article

References (38)

1. Baak JPA, van Diest PJ, Ariens ATh, van Beek MWPM, Bellot SM, Fijnheer J, van Gorp LHM, Kwee WS, Los J, Peterse HC, Ruitenberg HM, Schapers RFM, Schipper MEI, Somsen JG: The Multicenter Morphometric Mammary Carcinoma Project (MMMCP). A nationwide prospective study on reproducibility and prognostic power of routine quantitative assessments in the Netherlands. Path Res Pract 185:664-670, 1989.
2. Bagwell CB: Theoretical aspects of flow cytometry data analysis. In: Clinical flow cytometry. Principles and application, Bauer KD, Duque RE, Shankey TV (eds). Williams & Wilkins, Inc: Baltimore 1993, pp 41-61.
3. Beerman H, Kluin PhM, Hermans J, Velde CJH van de, Cornelisse CJ: Prognostic significance of DNA-ploidy in a series of 690 primary breast cancer patients. Int J Cancer 45:34-39, 1990
4. Bergers E, Diest PJ van, Baak JPA: Reproducibility of semi-automated cell cycle analysis of flow cytometric DNA-histograms of fresh breast cancer material. Anal Cell Path 8:1-13, 1995.
5. Bergers E, Montironi R, Diest van PJ, Prete E, Baak JPA: Interlaboratory reproducibility of semi-automated cell cycle analysis of flow cytometric DNA-histograms obtained from fresh material of 1295 breast cancer cases. Hum Pathol 27:553-560, 1996.
6. Bosari S, Lee AKC, Tahan SR, Figoni MAT, Wiley BD, Heatley GJ, Silverman ML: DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma. Cancer 70:1943-1950, 1992
7. Clark GM, Dressler I.G, Owens MA, Pounds G, Oldaker T, Mcguire WL: Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. N Engl J Med 320:627-633, 1989.
8. Collan Y, Klemi P, Kallioniemi OP, Joensuu H, Nordling S, Eskelinen M: Significance of variation in DNA flow cytometric analysis from paraffin-embedded breast cancers. Path Res Pract 188:581-586, 1992
9. Cornelisse CJ, Velde van de CJH, Caspers RJC, Moolenaar AJ, Hermans J: DNA ploidy and survival in breast cancer patients. Cytometry 8:225-234, 1987.
10. Dean PN, Jett JH: Mathematical analsis of DNA distributions derived from flow microfluorometry. J Cell Biol 60:523-527, 1974.
11. Ewers SB, Løngström E, Baldetorp B, Killander D: Flow cytometric DNA analysis in primary breast carcinomas and clinicopathological correlations. Cytometry 5:408-419, 1984
12. Ferno M, Baldetorp B, Borg A, Olsson H, Sigurdsson H, Killander D: Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome. Acta Oncologica 31:157-165, 1992.
13. Fisher B, Gunduz N, Costantino J, Fisher ER, Redmond C, Mamounas EP, Siderits R: DNA flow cytometric analysis of primary operable breast cancer. Cancer 68:1465-1475, 1991.
14. Haag D, Feichter G, Goerttler K, Kaufmann M: Influence of systematic errors on the evaluation of the S-phase portions from DNA distributions of solid tumors as shown for 328 breast carcinomas. Cytometry 8:377-385, 1987.
15. Joensuu H, Toikkanen S, Klemi PJ: DNA Index and S-phase fraction and their combination as prognostic factors in operable ductal breast carcinoma. Cancer 66:331-340, 1990
16. Kallioniemi OP, Hietanen T, Mattila J, Lehtinen M, Lauslahti K, Koivula T: Aneuploid DNA Content and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer. Eur J Cancer Clin Oncol 23:277-282, 1987.
17. Kallioniemi OP, Blanco G, Alavaikko M, Hietanen T, Mattila J, Lauslahti K, Lehtinen M, Koivula T: Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction. Cancer 62:2183-2190, 1988
18. Kallioniemi OP, Visakorpi T, Holli K, Heikkinen A, Isola J, Koivula T: Improved prognostic impact of S-phase values from paraffin-embedded breast and prostate carcinomas after correcting for nuclear slicing. Cytometry 12:413-421, 1991.
19. Klintenberg C, Wallgren A, Bjelkenkrantz K, Cartenssen J, Humla S, Nordenskjöld B, Skoog L: DNA distribution, cytosol estrogen receptors and axillary nodes as prognostic predictors in breast carcinoma. Acta Radiol Oncol 24:253-258, 1985.
20. Kute TE, Muss HV, Cooper MR, Case LD, Buss D, Stanley V, Gregory B, Galleshaw J, Booher K: The use of flow cytometry for the prognosis of stage II adjuvant treated breast cancer patients. Cancer 66:1810-1816, 1990.
21. Merkel DE, Winchester DJ, Goldschmidt RA, August CZ, Wruck DM, Rademaker AW: DNA flow cytometry and pathologic grading as prognostic guides in axillary lymph node negative breast cancer. Cancer 72:1926-1932, 1993.
22. Muss HB, Kute TE, Smith LR, Booher C, Long R, Kammire L, Gregory B, Brockschmidt JK: The relation of flow cytometry to clinical and biologic characteristics in women with node negative primary breast cancer. Cancer 64:1894-1900, 1989.
23. O'Reilly SM, Camplejohn RS, Barnes DM, Millis RR, Allen D, Rubens RD, Richards MA: DNA index, S-phase fraction, histological grade and prognosis in breast cancer. Br J Cancer 61:671-674, 1990.
24. Rabinovitch PS: Multicycle AV, Advanced Version. DNA Content and Cell Cycle Analysis Software. Manual. Phoenix Flow Systems, San Diego, CA, 1994, pp 3.27-3.28.
25. Rabinovitch PS: Practical considerations for DNA content and cell cycle analysis. In: Clinical Flow Cytometry: Principles and Application. Bauer KD, Duque RE, Shanky TV (eds), Williams & Wilkins, Inc., Baltimore, 1993, pp. 117-142.
26. Shanky TV, Rabinovitch PS, Bagwell B, Bauer KD, Duque RE, Hedley DW, Mayall BH, Wheeless L: Guidelines for implementation of clinical DNA cytometry. Cytometry 14:472-477, 1993.
27. Sigurdsson H, Baldetorp B, Borg A, Dalberg M, Fernö M, Killander D, Olsson H, Ranstam J: Flow cytometry in primary breast cancer: Improving the prognostic value of the fraction of cells in the S-phase by optimal categorization of cut-off levels. Br J Cancer 62:786-790, 1990.
28. Sigurdsson H, Baldetorp B, Borg A, Dalberg M, Ferno M, Killander D, Olsson H: Indicators of prognosis in node-negative breast cancer. New Engl J Med 322:1045-1053, 1990.
29. Silvestrini R and SICCAB group: Quality control for evaluation of the S-phase fraction by flow cytometry: A multi-center study. Cytometry 18:11-16, 1994
30. Stål O, Wingren S, Carstensen J, Rutqvist LE, Skoog L, Klintenberg C, Nordenskjöld B: Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variable in primary breast cancer. Eur J Cancer Clin Oncol 25:301-309, 1989.
31. Toikkanen S, Joensuu H, Klemi P: The prognostic significance of nuclear DNA content in invasive breast cancer-a study with long-term follow-up. Br J Cancer 60:693-700, 1989.
32. Toikkanen S, Joensuu H, Klemi P: Nuclear DNA content as a prognostic factor in T1-2NO breast cancer. Am J Clin Pathol 93:471-479, 1990.
33. Uyterlinde AM, Baak JPA, Schipper NW, Peterse H, Matze E, Meijer CJL: Further evaluation of the prognostic value of morphometric and flow cytometric parameters in breast-cancer patients with long follow-up. Int J Cancer 45:1-7, 1990.
34. Vindelov LL, Christensen IJ, Nisses NI: A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3:322-327, 1983
35. Weaver DL, Bagwell CB, Hitchcox SA, Whetstone SD, Baker DR, Herbert DJ, Jones MA: Improved flow cytometric determination of proliferate activity (S-phase fraction) from paraffin-embedded tissue. Am J Clin Pathol 94:576-584, 1990.
36. Wersto RP, Liblit RL, Koss LG: Flow cytometry DNA analysis of human solid tumors: A review of the interpretation of DNA histograms. Hum Pathol 22:1085-1098, 1991.
37. Wersto RP, Stetler-Stevenson M: Debris compensation of DNA histograms and its effect on S-phase analysis. Cytometry 20:43-52, 1995.
38. Witzig TE, Ingle JN, Cha SS, Schaid DJ, Tabery RL, Wold EW, Grant C, Gonchoroff NJ, Katzmann JA: DNA ploidy and the percentage of cell in S-phase as prognostic factors for women with lymph node negative breast cancer. Cancer 74:1752-1761, 1994.